Fresenius Medical Care AG & Co. KGaA

General ticker "FMCQF" information:

  • Sector: Health Care
  • Industry: Medical - Care Facilities
  • Capitalization: $14.0B (TTM average)

Fresenius Medical Care AG & Co. KGaA does not follow the US Stock Market performance with the rate: -28.5%.

Estimated limits based on current volatility of 0.4%: low 44.76$, high 45.10$

Factors to consider:

  • Company pays dividends (annually): last record date 2026-05-25, amount 1.73$ (Y3.88%)
  • Total employees count: 47521 as of 2005
  • Earnings for 15 months up through Q1 (+1 year) exceed our estimates

Stock Forecast*

* forecast is subjective and experimental, should not be used for any investment decisions

Long term estimates were made for the period from 2024-12-31 to 2026-12-31

  • 2024-12-31 to 2025-12-31 estimated range: [40.99$, 61.53$]
  • 2025-12-31 to 2026-12-31 estimated range: [43.77$, 65.48$]

Financial Metrics affecting the FMCQF estimates:

  • Negative: with PPE of 22.8 at the end of fiscal year the price was high
  • Positive: Operating cash flow per share per price, % of 18.66 > 12.93
  • Positive: -5.34 < Operating profit margin, % of 7.20
  • Positive: 1.77 < Return on assets ratio (scaled to [-100,100]) of 2.16
  • Positive: Interest expense per share per price, % of 3.18 <= 3.34
  • Positive: 42.57 < Shareholder equity ratio, % of 43.43 <= 64.23
  • Positive: -0.03 < Industry operating cash flow per share per price (median), % of 2.59
  • Positive: Industry inventory ratio change (median), % of 0 <= 0

Similar symbols

Short-term FMCQF quotes

Long-term FMCQF plot with estimates

Financial data

YTD 2023-12-31 2024-12-31 2025-12-31
Operating Revenue €19,453.62MM €19,335.91MM €19,620.65MM
Operating Expenses €18,084.18MM €17,943.51MM €17,783.34MM
Operating Income €1,369.44MM €1,392.39MM €1,837.31MM
Non-Operating Income €-336.42MM €-335.47MM €-325.88MM
Interest Expense €424.64MM €407.04MM €384.86MM
R&D Expense €231.97MM €183.49MM €157.94MM
Income(Loss) €1,033.02MM €1,056.93MM €1,511.43MM
Taxes €300.56MM €316.06MM €320.88MM
Net Income(Loss)* €499.00MM €537.91MM €977.63MM
Stockholders Equity €13,620.26MM €14,576.56MM €13,304.85MM
Inventory €2,179.18MM €2,067.92MM €2,140.20MM
Assets €33,929.81MM €33,566.58MM €30,990.39MM
Operating Cash Flow €2,628.80MM €2,386.14MM €2,679.99MM
Capital expenditure €684.60MM €699.36MM €915.03MM
Investing Cash Flow €-544.23MM €-84.94MM €-693.29MM
Financing Cash Flow €-1,858.53MM €-2,569.30MM €-1,431.65MM
Earnings Per Share** €1.70 €1.83 €3.36

* Profit(Loss) attributable to entity.
** EPS are Split Adjusted, recent splits may be reflected with a delay.